ash
26 June 2026
Aza-Venetoclax Outperforms Intensive Chemotherapy in AML: ASH 2025 Trial Data — What It Means for Patients
Rethinking How We Treat Acute Myeloid Leukaemia — New Trial Data Is Changing the Conversation For decades, the treatment of acute myeloid leukaemia (AML) has followed a fairly consistent script: inten
Read Article